Table 1

Lymphoma characteristics, conditioning regimens, side effects and outcome of the two female patients so far studied, after haematopoietic stem cell transplantation

  • 1-150 NHL = non-Hodgkin's lymphoma; MALT = mucosa associated lymphoid tissue; F-MACHOP: F = 5-fluorouracil, M = methotrexate, A = Adriamycin, C= cyclophosphamide, H = doxorubicin, O = Oncovin, P = prednisone; ARA-C = arabinoside-C; VP16 = etoposide; CTX = cyclophosphamide; BCNU = carmustine; MNC = mononuclear cells; PMN = polymorphonuclear cells; Plt = platelets; VACOP-B: V = Vepesid, A = Adriamycin, C = cyclophosphamide, O = vincristine, P = prednisone, B = bleomycin; VIPE: V = vinblastine, I = ifosfamide, P = prednisone, E = etoposide.